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ABSTRACT
Garcia, Aaron N. M.S., Department of Physics, Wright State University, 2007.
Comparative Investigation of Dosimetric Tools in IMRT.

Verification of the isodose distribution delivered to the planned tumor volume is
required for quality assurance in the clinic. Verification in this context means ensuring
that the actual dose delivered to a volume matches the dose that a computerized planning
system intended that volume to receive. The computerized planning is performed by a
Computerized Medical Systems (CMS) Intensity Modulated Radiation Therapy (IMRT)
plan. Two methods of measuring the delivered dose are film dosimetry and diode
dosimetry. This project will compare the relative isodose distribution profiles of film
dosimetry and MapCheck (Sun Nuclear Corporation, a diode-based dosimetry system) to
the relative isodose distribution profile of the CMS IMRT plan.
Two IMRT plans were used that were intended to deliver 7500centigray to the
prostate. These plans were then performed while measuring the isodose distributions
using the above two techniques. The two techniques were compared on the basis of time
efficiency and accuracy.
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I. INTRODUCTION
Successful clinical implementation of an Intensity Modulated Radiotherapy
(IMRT) program requires patient-specific verification of the complex dose distributions
generated by the Treatment Planning System (TPS). These calculations may be verified
through accurate two dimensional (2D) dosimetric measurements. This requirement is
necessary to assure that the prescribed dose is being delivered to the patient. And
although, the TPS dose distribution may be deemed as the golden standard, there may
exist calculation inaccuracies, which may be evaluated through differences between 2D
measurements and calculations.
To enable a treatment planning system to perform IMRT calculations there is a
series of procedures that must be executed. The evolution of these procedures is referred
to as the commissioning process. This process is essential and required for any IMRT
clinic.
Firstly, in the commissioning process, an extensive set of measurements are
taken. These measurements include depth-dose, in-plane/cross-plane, and wedge profiles
for different field sizes to name a few. Secondly, the data obtained is imported into the
TPS to verify that the beam models produced by measurement closely match the Monte
Carlo models that lie within the TPS. The model of each set of measurement is
interpolated to obtain an averaged model, which becomes an integral component of the
data used for calculating dose. Finally, once all the models have been imported and
interpolated, a simple treatment plan is generated to verify that the dose delivered to a
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point in the TPS is accurately reproduced by a measurement taken within a water
phantom. Errors in computation by the treatment planning software, possibly due to
errors in the data used as input to the TPS commissioning process, would be identified
and corrected at this stage.
Once the commissioning process is complete, the TPS dose predictions are then
expected to be “correct”. However, extensive calibrations of the linear accelerator and
the TPS system are performed on a monthly and a yearly basis. For safety reasons it is
necessary to check the 2D doses on a per patient basis since changes in the linear
accelerator or software errors can occur, rarely, between calibrations. Possible errors are
changes in output of the linear accelerator (Linac) and in-plane/cross-plane profiles of the
beam. Changes in output are the least possible of the two since the output of the machine
is checked routinely on both a daily and monthly basis.
Most errors that arise in calculated and measured comparisons are due to poor
measurement tool calibration (i.e. dose and array calibration, processing), and inherently
weaker resolution of the measuring tool. The former may be nearly eliminated with
careful calibrating procedures, but the latter is only improved by the advancements in
resolution –based measurement technology. A large source of difficulty in per patient
calibration is the execution per patient measurements. Additionally, dosimetric
measurement contains most of the disagreement since factors such as positioning,
processing, scanning, and etc. must be performed with high precision. Furthermore,
inaccuracies are prevalent in any radiation therapy clinic. Therefore, 2D measurements of
IMRT plans are imperative to maintain the integrity of both the software of the treatment
planning system, and the linear accelerator executing the delivery.
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Traditionally, clinical physicists have used ionization chamber dosimetry
combinations to determine absolute doses at specified points within the field of
irradiation. Ionization chamber measurements are commonly the device used to
commission IMRT treatment planning systems. In recent studies, EDR2 film has proven
to be a quality dosimeter resulting in measurements with relative differences between 25%12 of the treatment planning system data. Film is capable of measuring doses in 2
dimensions. Another option for 2D dosimetry is a diode array system. Diodes have
shown promise, with differences of 1-3%7 between the diode and the ionization chamber.
However, a comparison between Kodak’s EDR-2 film and a diode array system for
fluence map measurements needs to be performed.
For the purposes of our study, IMRT prostate plans derived from Computerized
Medical Systems (CMS) treatment planning system were delivered to both EDR2 film
and MapCheck (2D diode array system). MapCheck and EDR2 film relative isodose
distribution were quantitatively compared to that of the isodose distribution generated by
the CMS IMRT plan. The efficiency, in terms of operator time, of the two 2D verification
methods was also compared.
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II. BACKGROUND & THEORY
Physics of X-Ray Production
Radiation therapy consists of the delivery of X rays to a tumor in an
attempt to kill tumor cells. X rays are generated by accelerating a stream of electrons
towards a metallic target. The metal used for the target is generally tungsten (Z=74)
because of its high melting point, which is important because of the intense heat
produced in the target by the electronic bombardment. There are two mechanisms by
which x rays are produced. The first is through bremsstrahlung (braking radiation),
whereby photons are produced with various energies up to the maximum energy of the
incident electron. The latter mechanism is the production of characteristic x rays with
discrete energies.
The production of bremsstrahlung x rays is exhibited in the following interaction:

Figure II.1: Diagram showing the production of bremsstrahlung x-rays [1].
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Bremsstrahlung x rays is the result of a radiative interaction between a high-speed
electron and a nucleus. In this particular interaction, an electron becomes deflected from
its path by the coulomb force of attraction, whereby it loses its energy by bremsstrahlung.
The photon created from this interaction may have energy up to the initial energy of the
electron. Bremsstrahlung x rays are those which are generally produced via transmission
type targets because of its usability for radiation therapy.
Characteristic x ray production is the other type of mechanism for x ray
production, which may be visualized by the following interaction:

Figure II.2: Diagram showing the production of characteristic x-rays [1].

An electron incident on an atom with kinetic energy E0 may interact and eject
orbital electrons providing that it has sufficient energy equal or greater to the electron in
the particular orbital which it is trying to eject. Once ejection has occurred, the atom
becomes ionized. This vacancy becomes filled by an outer orbital electron releasing
electromagnetic

radiation

or

“characteristic”
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radiation.

Unlike

bremsstrahlung,

characteristic x rays are produced at discrete energies; hν =Ek-El, where Ek and El are
equal to binding energies of the K and L shell, respectively.
X-Ray Tube
The conventional x ray tube consists of glass envelope evacuated to a high
vacuum, a cathode and anode. The cathode or negative electrode is a tungsten filament
that when applied with sufficient tube current heats up and releases electrons by a process
called thermionic emission. The anode consists of thick copper rod at the end of which is
placed a small piece on tungsten target. The electrons produced at the cathode are
accelerated by a high potential difference applied between the cathode and the anode to
achieve high velocities. The kinetic energy that the electrons obtain through the potential
difference applied is proportional to the energy that the resultant photons or x rays will
have. The x ray beam emerges through a glass window in the tube envelope.

Figure II.3: Diagram of a conventional x-ray tube [1].
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Linear Accelerator
The medical device use for radiation therapy today is the linear accelerator, or
commonly referred to as the linac. The linac uses high frequency electromagnetic waves
to accelerate charged particles such as electrons to high energies through a linear tube.
The electrons accelerated through the wave guide system evolve from high-voltage
pulses in the modulator section which are flat-topped DC pulses of a few microseconds in
duration. These pulses are delivered to both the electron gun and magnetron
simultaneously. Pulsed microwaves produced in the magnetron are injected through the
waveguide system into the accelerator tube. The interaction of the electrons produced in
the electron gun and the electromagnetic field of the microwaves gives the electrons
sufficient energy for the production of the x ray beam via bremsstrahlung. The x ray
beam emerged from the exit window of the accelerator tube is in the form of a pencil
beam of 3mm in diameter.

Figure II.4: Diagram exhibiting the internal structure of a linear accelerator.
(Courtesy: Siemens Medical Systems, Inc).
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The linear accelerator is predominantly used for photon and electron beam
therapy. Photon or x ray beams are produced via bremsstrahlung, whereby an electron
beam strikes a target. Since linear accelerators produce electrons in the megavoltage
range, the x ray intensity is peaked in the forward direction. The x ray beam produced
from this interaction contains a wide range of x ray energies in which their angular
distribution is energy dependent, which may be observed in the following figure:

Figure II.5: Diagram showing the angular distribution dependence of x-rays on energy [1].

Since there is an angular dependence of x rays on energy, there is a lack of
intensity homogeneity, thus the necessity of using a flattening filter for therapeutic
applications. The flattening filter, generally made from lead, is inserted into the path of
the beam to create a uniform intensity distribution across the field.
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The flattened x ray beam or electron beam is incident on dose monitoring
chambers. The monitoring system consists of several ion chambers or single chamber
with multiple plates, in a vacuum, so that the ion chambers are not affected by changes in
temperature or pressure. The function of the ion chamber is to monitor dose rate,
integrated dose, and field symmetry.
The treatment beam geometry is set by two sets of collimators: a fixed primary
collimator located immediately beyond the x-ray target and a movable x ray collimator
which is located directly beneath ion chamber and the flattening filter. The movable x ray
collimator may be adjusted such that the field projected onto the patient ranges from 0x0
to 40x40. In addition, a multileaf collimating system is conventionally used to further
shape the beam to conform to the asymmetry of the tumor.
An electron beam is used for the treatment of superficial tumors. The beam,
instead of striking a target, strikes a scattering foil to spread the beam as well as get
uniform electron fluence across the treatment field. The scattering foil consists of a thin
metallic metal foil, usually of lead.
The electron collimating system is quite different from its counterpart because
electrons scatter readily in air. This necessitates a beam collimation close to the skin
surface of the patient. This constraint is resolved by attaching an auxiliary collimator,
more commonly referred to as a cone.
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Biological Effects of Radiation
Electromagnetic radiation (both x rays and gamma rays) are able to produce
biological damage indirectly. They release their energy via collision with molecules in
the body. This produces high-speed electrons which ultimately produce the biological
damage to tissues. When X rays enter biological material, their energy is converted into
heat in the form of thermal energy which breaks chemical bonds, thereby disrupting key
cellular processes leading to cell death.
Biological effects correlate with the amount of radiation supplied to tissues. That
is, greater amounts of radiation (dose) cause greater damage to tissues than lesser
amounts .However, tissues composed of malignant cells or normal dividing cells differ
from normal non-dividing cells in their response to ionizing radiation in that they are
more sensitive to radiation. This is because such cells are more likely to be in the mitotic
phase and less likely to be in the nuclear replication or the S phase. The sensitivity of
malignant cells to ionizing radiation is an important factor in making radiation therapy
useful.
In radiation therapy, dose is administered through fractionation. That is, an equal
amount of dose is given daily over the treatment period. Fractionation is a very important
principle in radiobiology in that it prevents many of the biological consequences of
radiation, such as, repair of sublethal damage, reassortment, and accelerated population.
Repair of sublethal damage from radiation can occur if sufficient time is permitted
between fractionations. However, fractionation also permits reassortment of cells from
less sensitive S phase to more sensitive mitotic phase. In addition, only tumors have areas
of relative hypoxia- these areas are relatively radioresistant because radiation effects are
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enhanced by oxygen; when sufficient doses of radiation are given to kill their oxygen rich
counterpart, these oxygen deprived cell redistribute into more oxygen friendly
environments. Thus, fractionation allows increased tumor killing by allowing these cells
to redistribute into more sensitive phases and allows less oxygenated tumor cells to
become more oxygenated. However, normal tissues do not have these areas of hypoxia so
fractionation would tend to spare these tissues.

Treatment Planning
Radiation therapy treatment planning and treatment delivery has taken a huge leap
in the last two decades or so. This rate of change has been spearheaded by the advances
in computer software and hardware.
These advances in treatment planning and treatment delivery systems have led to
the implementation of Three Dimensional Conformal Radiation Therapy (3DCRT). The
mission of 3DCRT is to conform the spatial distribution of the prescribed dose to the 3D
target volume; the malignant tumor. The delivery of 3DCRT is accomplished by shaping
the beam of incidence to fit the target volume at fixed beam directions or rotations. The
intensity of these beams are of uniform fluence, thereby necessitating the use of beam
modifying devices, such as a wedge or a compensator to create a radiation projection
(dose distribution) that is suitable and optimal for the plan in question.
In the history of radiation oncology, wedges and compensators have been utilized
to reconcile missing tissue and shape dose distribution. Although, these types of
compensators have served a good purpose, the manufacturing of these tools are labor
intensive, and are too restrictive a view of intensity modulation, in that the primary goal
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in using wedges is for enabling non-opposed beam arrangements and missing tissue
compensation, whereas, IMRT is capable of generating concave dose distributions. These
sharp, concave (high-dose gradient) isodose distributions provide specific sparing of
sensitive normal structures and escalation of dose to the tumor, within complex treatment
geometries. With IMRT, the beam intensity is made to be proportional to the target
thickness as assessed from a beam’s eye view as the beam is angled around the patient.
More clearly, the beam intensity is at its greatest for “thicker” targets, as opposed to
weaker beam intensity for “thinner” targets. Therefore, determining the optimal beam
fluence is the essential component of IMRT.
Treatment planning in IMRT is very complex because of its varying degrees of
freedom. Mathematical optimization is essential, and the determination of the optimal
fluence, which is referred to as inverse planning, is of paramount importance. Inverse
planning may be approached in two ways; 1) mathematical methods and algorithms from
image reconstruction, and 2) calculating the optimum fluence profiles directly from the
desired dose distributions using simulated annealing and the superposition-convolution
method.
In CT imaging, data is acquired from transmission values for a series of small
pencil beams of radiation from various directions through the patient. The process of data
acquisition is conceptually the same for all geometries, but the details of image
reconstruction vary depending on the acquisition geometry. Each transmission
measurement is a product of transmission values through the individual pixels in the path
of a pencil beam.

Tn =

In
= ∏ e − µρi∆x
Io
i
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(equation II.1)

The logarithm of a transmission measurement is proportional to the total density of the
tissue traversed by the corresponding pencil beam, which is denoted by the following
equation,
ln Tn = − µ∆x ∑ ρi

(equation II.2)

i

where Tn is the transmission value of the pencil beam, µ is the mass attenuation
coefficient, ∆x is the linear dimension of each CT reconstruction pixel, and ρi is the
density of tissue in the ith pixel.
The methodology that CT image reconstruction uses is called backprojection,
whereby the data acquisition process is reversed. The total density measured by each
pencil beam is distributed among the individual pixels in traversed by it. Clearly stated, it
essentially redistributes the appropriate fraction of the total density to each pixel along
the original linear plane in which it traversed. In this particular algorithm, the overlapping
back projections positively reinforce the high density regions and negatively reinforce the
low density regions areas to produce a blurred approximation of the true patient cross
section. The blurring effect of reconstruction is well-understood and may be removed by
filtered back projection. In filtered backprojection, the reconstructed image is
deconvolved using a known point spread function.
The backprojection principle used in CT imaging, can be applied to inverse
planning. The patient is divided into a series of 2D cross sectional planes similar to CT
images. Each treatment beam cross-section is divided into a 2D array of pencil beams in
such a way that each 2D patient cross-section corresponds to a line of pencil beams. The
fluence values for the pencil beams are then combined into one dimensional fluence
profiles through the treatment beam. The one dimensional fluence profiles are then
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combined to create a two dimensional fluence profile, which can be more amply
characterized as the dose distribution. This is comparatively the same as CT imaging
except that tissue density is replaced by radiation dose. Furthermore, the mission of the
treatment planning system is to provide a set of pencil beam fluence values that will
produce an optimal treatment plan.
With this is approach, an ideal isodose distribution is assigned to the patients
cross section with an applied projection operator similar to the one used for image
reconstruction. This would yield a uniform target dose to the target volume and zero dose
everywhere else. The projection operator sums the doses along a beam ray onto the
incident beams to give an approximation to the inverse transformation from dose
distribution to intensity profile. Fluence profiles ascertained by the process are
normalized to provide the required dose to the isocenter.

This process, although

seemingly accurate in terms of its ability to deliver the prescribed dosage to the isocenter,
it is very inaccurate with respect to uniformity of dose to the target. This anomaly can be
corrected by filtering, but that would yield undesirable negative beam fluences.
Correction of the previous method was needed in order to provide a true
representation of the isodose distribution. Thus, the convolution-superposition method
was established. The convolution-superposition method is a model-based algorithm.
Model based algorithms compute the dose distribution with a physical model that
simulates the actual radiation transport. Model based distributions maintain the ability to
model the primary photon fluence incident at a point and the distribution of energy
subsequent to primary photon interaction, which further allows it to simulate the transport
of scattered photon and electrons away from the interaction site.
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The convolution superposition method utilizes a convolution equation that
considers both the transport of primary photons and that of the scatter photon and
r
r
electron emerging from the primary photon interaction. The dose D (r ) at a point r is
denoted:

r
r
r r
r
µ
D(r ) = ∫ Ψp(r ′) A(r − r ′)d 3 r ′

ρ

r
r r
r
= ∫ T p (r ′) A(r − r ' )d 3 r ′
where

(equation II.3)

(equation II.4)

µ
r
is the mass attenuation coefficient, Ψp (r ′) is the primary photon energy
ρ

r r
fluence, and A(r − r ′) is the convolution kernel, which is a matrix of dose distribution
deposited by scatter photons and electron set in motion at the primary photon interaction
r
site. Tp (r ′) is the reduced form and the product of the mass attenuation coefficient and
the primary energy fluence, which is commonly referred to as terma. Terma stands for
total energy released per unit mass. This term is analogous to kerma, which is the total
kinetic energy released per unit mass in the form of electrons set in motion by photons.
One of the main reasons for using the convolution is speed. It turns out that you
obtain the convolution if you perform the Fast Fourier Tansform (FFT) on both the kernel
and the open area in three dimesions, multiply the two functions together and then take
the inverse FFT. The other main reason for using convolution is to add up the three
dimensional scatter to a point so that you receive a more accurate representation of the
dose distribution, which is especially important when inhomogenities are present.
The CMS planning system, specifically, uses an algorithm referred to as the
pencil beam algorithm, which is a form of the previously discussed convolution-

15

superposition. In addition, it collaboratively uses an optimization algorithm, which
minimizes the cost function in order to meet the dosage criteria input by the user.
The pencil beam algorithm includes dose from the primary pencil beam plus
scatter. The pencil beams are always corrected to give the same result as the input
calculation (FFT or convolution superposition) so they contain the essence of the robust
algorithms. The lateral extents are computed using the following:
x < − x0
− x0 ≤ x ≤ x 0
x0 < x

f ( x, b, x0 ) = sinh(bx0 ) exp(bx)

(equation II.5)

f ( x, b, x0 ) = 1 − exp(−bx0 ) cosh(bx0 ) (equation II.6)
f ( x, b, x0 ) = sinh(bx0 ) exp(−bx)

(equation II.7)

where x0 is the width of the pencil beam, x is the distance from the center to the
end of the beam ,b is the parameter that controls the fit, and f(x,b,x0) is the correction
factor for lateral scatter. The computation of lateral scatter in the final dose calculation is
of significant importance because an IMRT beamlet, typically an area of 1x1cm field,
shows severe perturbation because of electronic disequilibrium. This disequilibrium has a
reduced dose because of the streaming of electrons laterally. Dose is then computed by
“convolving” this lateral scatter model with the TERMA. Thus, the dose is calculated by
the following:
dose( x, y, d ) = TERMA( x p , y p , d ) ⋅ f ( x r , bx , x0 ) ⋅ f ( y r , b y , y 0 )

(equation II.8)

Ideal dose distributions are very difficult to attain, since there is ongoing battle
between what the users would like as their distribution to look like and what the physics,
and the computer, constrained by the physics, can produce. Therefore, the optimization
algorithm is created to arrive at a set of values for some variables (we might call these the
“driving variables”) which determine some other dependent parameters (we might call
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these “driven variables” and which correspond to the global minimum in some third
quantity (which we will call the “cost function”) dependent in turn on these other
dependent parameters. First, we identify that, at each iterative step, taking some action
has a known or predictable effect on some other dependent driven quantity. It is the
minimization of the cost which is the goal of optimization. This may be better explained
mathematically; The total cost to be minimized:
M

F = ∑ fσ

(equation II.9)

σ =1

where fσ is the individual subcost of the objective. A typical subcost function is
essentially the driven variable which contains the driving variables, which is represented
in the following:

fσ =

wσ
N

N

∑ gσ (D )
i

(equation II.10)

i =1

Where wσ is an importance weighting, N is the number of structure voxels, Di is
the dose at voxel i, and gσ ( Di ) is the cost per voxel at voxel i, For a simple goal dose,
quadratic error approach, the cost per voxel would be:
g σ ( Di ) = ( Di − D0 ) 2 (equation II.11)
where D0 is the goal dose for the objective. The goal dose may be set in various ways.
The user may select to choose minimum and maximum objectives that compromise
mathematically to achieve the goal dose, or simply set the goal dose without any min or
max dose objectives. These max and min goal objectives may be computed through the
following:
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0 ≤ Di ≤ D0 ⇒ g σ ( Di ) = 0
D0 < Di ≤ D0+ ⇒ g σ ( Di ) = m+ ⋅ ( Di − D0 )

(equation II.12,13,14)

D0+ < Di ⇒ g σ ( Di ) = ( Di − D0+ ) 2 ⋅ m+ ⋅ ( Di − D0 )
where D0 is the threshold dose or Organs At Risk (OARs) of goal dose (Targets), D0+ is
the maximum acceptable dose, and m+ is a linear penalty for dose in excess of the goal
dose.
The optimization process can be lengthy if unreasonable parameters are selected
or if many dose calculation points are chosen, although more dose calculation points are
very small, which increases the accuracy and the integrity of the dose distribution, though
desired, lengthy. The optimization and planning process may be summarized by the
following diagram:

Figure II.6: Schematic of the process in a CMS/XIO Treatment Planning System.
(Courtesy: Computerized Medical Systems,Inc).
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The genius behind 3D IMRT is the utilization of multiple beams whose energy
fluence profiles are modulated in two dimensions so to create a uniform high dose region
that closely tailors to the asymmetrical shape of a tumor. This is achieved by using either
static modulating devices or a dynamic multileaf collimator. However, the use and
popularity of dynamic multileaf collimators is more acclaimed because of its ability to
produce much more complex dose profiles. These complex dose profiles are a fingerprint
to achieving higher quality treatments for the future.

Film Dosimetry
Film dosimetry can be used to obtain a detailed quantitative pattern of
radiation distribution. This quantitative pattern of radiation distribution is referred to as
an isodose distribution. The isodose distribution contains contours of equal dosage lines.
A dose calibration curve is used to determine quantatively correct dose values for the
isodose contours. Generally, both the isodose distribution and the dose calibration curve
can be created through imaging software. In addition to its functions for dosimetry, it
may serve other purposes. These purpose’s include checking the alignment of diaphragms
in treatment cones, the size and shape of a radiation field, the accuracy of a light
localizer, the size of penumbra around a field, leakage radiation around collimators, and
the positioning of special radiation fields.
Radiographic film serves as a reliable dosimetric verification tool in radiation
therapy. It is an in-phantom measurement of the dose that will be delivered to a malignant
tumor. Especially in IMRT, where the intensity is being modulated in a fashion as to
promote dose escalation(increase in dose to the tumor volume) and conformity,
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verification of dose in the region of treatment is of utmost importance. Overall, film is a
widely used dosimeter in situations that require a two-dimensional dose distribution.
Radiographic film consists of a plastic base coated with emulsion that contains
silver bromide (AgBr) grains and gelatin. The dose response characteristics are based on
the elemental composition of the grains and the density of the emulsion. However, the
size of the grains within the emulsion determines spatial resolution.
The creation of the latent image on direct exposure film initially occurs when
secondary electrons are set into motion by the primary photons of the incident radiation.
As the secondary electrons travel through the conduction band of the crystal lattice they
become trapped in the specks of the forbidden band, which are negatively charged. These
negatively charged specks attract interstitial ions, forming neutralized metallic silver; the
metallic silver is the latent image.
The mechanism alone in creating the latent image is not enough in order to
provide information for dosimetric purposes. Processing of the film is a vital portion of
the post-irradiation process. This process amplifies the latent image by a factor of 109.
The two steps that occur in processing are developing and fixing of the film. The former
step changes the silver halide grains into metallic silver by the application of a solution
that contributes electrons to the silver ions, and the latter removes all unexposed grains.
Due to the fact that the film response is function of the temperature, agitater, and
developer characteristics make this step integral in film dosimetry.
The blackening of radiographic films due to energy absorbed by the film can be
quantified as the optical density (OD):
OD = log(

Io
); I o > I
I

(equation II.15)
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Where Io is the intensity of the beam in air before reaching the film, and I is the
transmitted light intensity. The density or blackening of the film depends on the amount
of radiation reaching the film and the resulting mass of metallic silver per unit area. This
may be visualized by the following:

Figure II.7: Diagram exhibiting a developed radiographic film under film densitometer.

As one may notice, if the grains in the emulsion become larger so does the thickness, thus
reducing the spatial resolution of the film.
The practical energy range for diagnostic radiology is from 0-150keV.
This is attributed to the extraordinarily high response of silver (Z=47) to absorbed
radiation within that range and the predominant photoelectric effect. However, this
response becomes abysmal or “flat” at photon energies higher than 200keV.
Film properties must be known and studied in order to qualify it as viable tool for
dosimetric purposes. Properties such as speed and latitude are the most important for this
qualification. The former referred to as the film speed or film sensitivity (S) is a function
of the size of crystals making up the emulsion and the energy of the X rays striking the
target. For example, if the grains are large then fewer X ray interactions are required to
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blacken the film and, because of this, fast films are often called ‘grainy’ films as the
crystals when developed give a grainy picture. For therapeutic purposes, slow film is
required because of its increased resolution. Film speed may be further explained by the
following equation:
S=

1 1
=
It J

(equation II.16)

Where I is the intensity of the beam, t is the total time of the exposure J. The latitude or
linearity of the film is the useful exposure range of the film. The latitude or linearity may
be determined from a sensitometric curve or more commonly known as the Hunter &
Driffield (H&D) curve, which is a plot of the net optical density versus the dose. An
H&D curve is a characteristic curve which describes the response of photographic film to
light. There are two parts that make up the curve aside from the linear portion: 1) toe,
which is the portion of the curve before it becomes linear, and 2)shoulder, which is the
point of the curve after the linear portion where there is a change in concavity an is said
to be the saturation point of the film. For visible light interactions the toe and shoulder
are observed, however, for electron/photon (in this context, photons are the x rays
produced by an accelerator, which are not visible) interaction only the shoulder is
observed, which may be observed by the following H&D curve:
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Figure II.8: H&D curves of radiographic film to radiation

The linearity of the film is essentially the most important property of determining
what type of film to use for the verification of an IMRT plan.
The film of choice for IMRT plan verification is an Extended Dose Range (EDR)
film by Kodak. EDR film has a linear response with dose, from 0 to 350cGy, for 6MV
and 15MV photons. A sensitometric response such as this makes EDR a very good tool
for comparing isodose distributions since most fields in IMRT plans do not have doses
above 200cGy.

Diode Dosimetry
Semiconductor diodes, specifically silicon p-n junction diodes, are used in relative
dosimetry. They offer substantial advantages over other dosimetric tools because of their
high sensitivity, small size, and instantaneous response. The response of the
semiconductor diode has been compared to the dose response of a PTW (PTW
Hicksville, NY) Farmer chamber (cylindrical ion chamber) and the doses measured with
this diode are with in 2 % or better of the PTW Farmer chamber.
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Semiconductors are an intermediate between conductors and insulators in their
ability to conduct electrical current. They contain three types of energy bands, because of
the aggregation of atoms which form a crystal lattice. The bands that make up the
semiconductor are the conduction band, energy gap, and valence band. Temperature or
light excites the valence electrons out of these bands, freeing them to conduct current.
The vacant positions left behind by the freed electrons, also known as holes, can move
around as well, contributing to the flow of electricity. The energy needed to excite the
electron and hole is known as the energy gap. In semiconductors, a small energy gap
(compared to insulators) between the valence band and conduction band facilitates the
movement of electrons to the conducting band, thereby controlling the resistance. This
may be observed by the following schematic:

Figure II.9: Energy level diagram in a semiconductor

Another good quality of the semiconductor, since the valence and conduction
band do not overlap, is that current flow can be regulated.
Silicon diode use for dosimetry consists of covalently bonded silicon atoms
arranged in a crystal lattice which is doped with impurities. The element used to dope or
mix the crystal will determine its nature as an n-type or p-type silicon. Doping is the
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process of adding impurities to an intrinsic semiconductor to increase its ability to
conduct electricity. The difference in the number of valence electrons between the doping
material, or dopant, and host semiconductor results in negative (n-type) or positive (ptype) carriers of electricity. The dopant is known as an “acceptor” atom if it accepts an
electron from the semiconductor atom. It is known as a “donor” atom if it donates an
electron to the semiconductor atom. When a p-type semiconductor region is placed
adjacent to an n-type region, they form a diode, and the region of contact is called a p-n
junction.
The p-n junction is the essential component of semiconductor electronics. It
contains both a p-type material and an n-type material in contact with each other. The
area within the vicinity of the junction is known as the “depletion region”, because it is
depleted of mobile carriers (electrons and holes). This is because the electrons from the
n-type material have crossed the junction and diffused into the other side (p-type),
recombining with holes in that side. On the other hand, the holes from the p-type
material have diffused to the n-type material, recombining with electrons. The following
is an example of the p-n junction with the depletion zone:
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Figure II.10: Schematic diagram showing basic design of a silicon p-n junction diode

Because of this diffusion process, holes not covered by electrons are left in the n-type
material, while electrons not covered by holes are left in the p-type material. Known
as uncovered charges, these result in an over-all negative charge in the p-type
material and an over-all positive charge in the n-type material. Furthermore, the
depletion zone develops an electric field, which opposes further diffusion of majority
carriers once equilibrium has been reached. Thus, creating a separation of charges
that develops a potential across the depletion region, preventing further diffusion of
carriers across the junction. This potential, known as the potential barrier, is about
0.6- 0.7V in a typical silicon p-n junction.
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Electronically, a radiation diode detector is connected to an operational
amplifier with a feedback loop to measure radiation induced current. There is no bias
voltage applied. The circuit acts as a current-to-voltage transducer, whereby the
voltage readout at some point is directly proportional to the radiation induced current.
The radiation induced current is proportional to the amount of ions produced which is
proportional to the amount of radiation incident on the diode. The current measured is
proportional to the dose rate of the radiation passing through the diode, whereby an
electrometer is used to measure the current and integrate it in time. The time
integrated current is proportional to the dose.
The clinical applications of silicon diodes have become more pronounced
because of the vast advantages they offer for relative dose distribution measurements,
such as small size and high sensitivity. However, their drawbacks are attributed to
their energy, angular, and temperature dependence, in addition to, the effects of
radiation damage. Therefore, these units used for dose measurements must be
scrutinized in order to determine the efficacy and accuracy of each measurement.
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III. MATERIALS & METHODS
Measurements were performed using a Varian linear accelerator with an 80-leaf
Multi-collimating leaf (MLC) system, which involved the energy of 6MV only. All
IMRT calculations were done using the Computerized Medical Systems Planning System
with dose calculation points of 0.2x0.2x0.2cm3. This calculation is projected on a twodimensional plane at the depth of the 3.2cm within the planning system as the calculated
dose distribution. It is viewed in both film and MapCheck dosimetry software as a
grayscale “virtual film.”

Diode Array Measurements
Sun Nuclear’s MapCheck Model 1175 is a 2-dimensional therapy beam
measurement system intended for quick and precise quality assurance of the dose
distribution resulting from an IMRT plan or from any radiation field. The 2-d diode array
consists of 445 diode detectors arranged in 22cm octagonal grid. The 10x10 center
portion of the grid contains detectors with 7-mm spacing. The outer area surrounding the
center grid contains diodes with 14-mm spacing. The diode arrangement is shown in the
figureIII.1:
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Figure III.1: Arrangement of the detector grid pattern in MapCheck. The spacing of the
10 x 10 cm center diodes (blue) and the yellow diodes are 7 mm, and the outer diodes (pink/pale blue)
spacing is 14 mm.

Calibration for the MapCheck instrument consists of two parts: 1) Array Calibration
(performed when initially receiving the instrument), 2) Dose Calibration (Prior to
individual beam or composite beam measurements). Array calibration is a process of
determining the relative sensitivity differences between detectors in the MapCheck
instrument. These differences are stored as individual correction factors to be applied to
the raw measurements from each detector. The correction factors are generated with
reference to the central axis diode, so that every diode within the grid has the same
sensitivity. These correction factors become a part of a calibration file that is always
selected before initiating the Dose Calibration of the system. Dose calibration is a
procedure to convert the MapCheck relative dose values to absolute dose values by
applying a single correction factor to all detectors. Dose calibration is performed in a
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10x10 field with an SSD of 97.6cm with a dose delivered to the array of 200cGy
(assuming that the output of the machine is 1cGy/MU). This establishes a dose
calibration factor, which is then applied to all the array detectors in addition to the array
sensitivity

correction

factors

obtained

during

array

calibration.

Background

measurements are made automatically whenever power is applied. During exposure, each
detector generates charge proportional to the dose received at that point. Each charge
value is integrated, converted from analog to digital, and sent to the computer.
The diode used in fabrication of the MapCheck is an improved N-type silicon
diode. Each diode has an intrinsic buildup of less than 0.1gm/cm2 and an active area of
0.8x0.8mm2 and is specifically designed for dose measurements on the surface of the
patient. The response of the diode versus given dose is linear up to approximately
300cGy. There is saturation in the response above an accumulated exposure of about
300cGy, and thus will not record any additional dose produced in the diode cavity.
Therefore, the use of these diodes for verification of an IMRT plan is quite satisfactory
considering the total given dose to all fields is much less than 300cGy per treatment.
The following is a brief overview of the calibration and measurement procedure.
The manual is the best guide for a step by step procedure for calibration. The first step
prior to the use of MapCheck is to take the background correction factors and then
calibrate the diodes. This gives the relative sensitivities of all the diodes in the
MapCheck. These relative sensitivities are stored as correction factors for the diodes. The
measured values are normalized with these correction factors. In order to perform a
planar dose measurement, one needs to execute the following steps: Place the MapCheck
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on the table with the wire connector away from the gantry; line up the crosshairs in the
center diode. The placement of MapCheck is shown in the following figure:

Figure III.2: Placement of MapCheck on the couch for Background and Calibration.

Prior to taking background measurements, the tool bar shows “NO” and status bar is
“RED”. The light inidicator on the tool bar turns from “RED” to “BLUE” at the
completion and the background box shows “BLUE” and “YES”. The background data is
stored into the computer. From the “Setup Menu” select “Collect Background”, enter
time for background collection to two minutes, click “Apply” in order to apply the
background to the data to be collected, click to exit the background collection.
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Place the MapCheck on the treatment table as on the previous figure. The
geometry for the placement is given in Fig.III.4. Select “Calibrate Array” from the setup
menu, and then click on “Load Cal” and select file to open the file. A field size of 10x10
is used for calibration. Align the cross hair of the MapCheck to the crosshairs of the
gantry. Go to setup and click on “Calibrate Dose”, the MapCheck at this point will
receive an exposure of 200MU. Following, save the file under a specific name so that it
may be used for the measurement of the IMRT plan.

Radiation source

97.6cm

100cm

**********************************
MapCheck
Treatment Couch

Figure III.3: Placement geometry of the MapCheck

MapCheck was used to measure the fluence of each single beam individually of
the IMRT plan. The desired fluence was measured at a depth of 2.4cm Plexiglas (which
is the inherent buildup), which is equivalent to 3.2cm of water phantom. To measure each
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beam individually, the device is setup at the same treatment geometry as shown in the
following figure with the exception of the additional buildup.

Figure III.4: Set up of MapCheck with build up for fluence measurement

To continue with the measurement of each beam of the IMRT plan, load the
calibration file created in the preceding procedure. Click on the “Start” button on tool bar,
when LED on toolbar turns “Green” , Turn on the accelerator and give exposure
according to plan. Click “Stop” button when treatment has finished and save the file so
that it may be evaluated and analyzed.
MapCheck has software with tools to view, analyze and to evaluate results
quantatively. In addition, you may compare the isodose distributions visually with those
from the treatment plan to the measured. Measured data is opened using the “Open”
command on the file menu; treatment plan data is imported using the “Import” command
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on the file menu. Prepare the treatment file according to specific procedure for each
treatment planning as given in the manual. After preparing the Treatment Planning
System (TPS) file import the file. The data can be displayed in 2-d, 3-d and can be
normalized to any selected diode detector. The measured data set imported to the top left
section of the panel in the following figure, the TPS file is imported to the top right
section, the bottom right gives the x-direction profile of the measurement file for a
specific y-location and vice versa, and the bottom left is gray scale view which provides a
monochrome display convenient of detector location

Figure III.5: Panel showing the measured data, TPS file, comparison file and the profile in
the x-direction given in top right, left, bottom right and left respectively.

With the measured data and the TPS planning profile data in the two panels click
the compare button in the lower right, one can compare the measured with the TPS plan
from point to point, which is achieved through the help of “distance-to-agreement”
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(DTA), a quantitative evaluation technique. If a measured point fails to agree within p%
with the plan dose at that position or if there isn’t a TPS point at the diode measurement
position, then the plan dose points are tested to see if there is a higher value and lower
value within a radius “r” around the measured point. If both a higher value and lower
value are found, then it is assumed that there is an agreement at some intermediate point
within the radius, and the dose at the measured point is considered acceptable. The
following schematic provides a clear visual on how DTA analysis works:

Figure III.7 Distance to Agreement

By setting the DTA at 3mm and % difference to 3, the panel displays the number of
measured points, which are within 3mm of the TPS plan, and the difference in the
measured value is within 3% of the value obtained by the TPS. The panel shows the total
points compared, number passed at a set criteria, and number failed, and the % of points
passed. The measured points that fail are displayed as RED and points or detectors whose
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measured values are less than 3% of the TPS point are displayed as BLUE. Mostly the
points which fail are in high dose gradient region i.e. the penumbra or near field edges. It
should be mentioned that the TPS has much higher resolution than MapCheck, namely
there is a 2mm linear resolution for TPS pixels, and approximately 11 TPS points for
every diode.

Film Dosimetry Measurements
Radiographic Film dosimetry was performed using Kodak EDR-2 Film. All films
in this study were irradiated in planes perpendicular to the beam direction at source to
film distance of 100cm and water phantom buildup of 3.2cm. Digital images and data
analysis of films were obtained using a linear CCD array optical film scanner with 16bit
resolution (VXR-16 Dosimetry Pro) together with commercial film dosimetry software
(RIT 113 Dosimetry System Version 4.0). Optical density-to-dose conversion was
accomplished using the Perpendicular Dose Calibration method described in the RIT
users’ guide (described below). The calibration films were exposed, developed, and
scanned at the same time as the measurement films for a given depth.
To create a calibration curve for the measured data (i.e. treatment film), 13 films
must be exposed at known doses to achieve optical density-to-dose conversion or H&D
Curve. Therefore, monitor units were chosen to deliver from 20cGy to 300cGy,
approximately, to each film, by using the following calculation:
Dose = MU × TMR ( f .s., depth, E ) × ISF

(equationIII.1)

Where TMR is the tissue maximum ratio for 10x10cm2 field size, a depth of 3.2cm, and
energy of 6MV. Since the machine is calibrated at 100ssd, an ISF or inverse square factor
must be used since an isocentric technique is applied in this calculation. Once this has
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been performed, each film must be scanned individually, and saved. Following, a
Perpendicular Dose Calibration method was used to create an H&D or characteristic
curve of the beam for the EDR-2 film, which is exhibited in the Fig.III.8. Doses beyond
300cGy were not chosen since the practical range for IMRT for all fields does not exceed
this dose.

Figure III.8 Calibration curve

In order for proper analysis of measured data to plan data, a software and physical
template must be created. The template serves as positioning tool. This tool is required
for pixel to pixel superimposition of the measured to plan data or dose point. Therefore,
each film, prior to exposure, must contain pin pricks or fiducial markers that coincides
with the template created in the software. The physical template was created by using a
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non-exposed processed film with an imprint of the cross hairs projected by the light field
of the linac, which is representative of a coordinate system. Following, pin pricks were
placed in the film at points on the grid measured from the isocenter (which are the same
location as the points created in the imaging software). The physical template lies over
the film to be exposed and pin pricks are placed at the aforementioned points so that these
markers are recognized by the imaging software when scanned.
Once the setup had been achieved, the particular film was exposed with the
corresponding treatment beam, which is shown in the following figure. After all films of
the treatment had been exposed, they were processed, scanned to measure the OD, and
saved and ready for evaluation.

Radiation source

96.8cm

100cm

Buildup phantom

3.2cm

Film
Backscatter Phantom

Figure III.9: Set up geometry for film dosimetry

Radiation Imaging Technology (RIT) software has tools to view, analyze, and
evaluate the results. Measured data is opened as the “target image”, whereby the
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calibration data created in the previous step and a median pass filter is applied- which
reduces down on film artifacts and image noise. Treatment plan data is imported and
opened as the “reference image”. These images are co-registered by applying the
template to the reference image and placing the virtual fiducial markers to the pin prick
marks on the target image. The data can be displayed in many ways and can be
normalized to any pixel or dose point on the image. However, for this project, the data
was displayed as a gamma histogram a vertical and horizontal profile comparison.
The scanning software used for film dosimetry scans at a spatial resolution of 356
x 356 microns2 per pixel. This means that the dose within a pixel dimension or “spot
size” represents the average dose or optical density of all grains within that area. It must
be mentioned that the diameter of silver grain is in the order of a micron (with an area
approximately equal to .79micron2), essentially yielding 160,425 grains per pixel
dimension. Although the measured pixels versus the TPS pixels have an approximate
ratio of 31:1, the film analyzing software adopts the treatment planning resolution by
averaging the 31 film pixels so that there is one metric film pixel for every TPS pixel.
This relative size ratio may be best visualized in the figure III.10:
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2000microns

356microns

2000microns

356microns

Figure III.10 relative size ratio between a TPS pixel and measured pixel before averaging

The R.I.T software employs the gamma index calculation to determine the
agreement between the TPS planar dose and the measured film planar dose. The
minimum radial distance between the measurement point and the calculation points
(expressed as a surface in the dose-distance space) is termed the gamma index. The
gamma index or gamma mean index represented by the gamma histogram combines the
dose difference measurement with the DTA. A gamma mean index value of greater than
one indicates a failure of the specified criteria. However, a value where the gamma mean
index is less than or equal to one, indicate the criteria has passed, and thus the measured
pixel passes. This is accomplished by evaluating all the nearest neighbor TPS pixels and
scoring a gamma index for each nearest neighboring pixel. In our case, a 3mm DTA
criteria with a 2mm measurement pixel linear resolution leads to the evaluation of 8
nearest neighbors. In the RIT software, the gamma is calculated using the following
square root quadratic equation:
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( DTAp ) 2 ( DDp ) 2
+
(C DTA ) 2
(C DD ) 2

(equationIII.2)

DTAp: distance from the measurement pixel to the calculated pixel
CDTA: DTA Tolerance (user input percent criteria)
DDp: dose difference between measurement pixel and calculated pixel
CDD: Dose Tolerance (user input percent criteria)

In order to find the approximate relationship between the number of diodes and
the number of pixels evaluated by the R.I.T. software we can use the ratio of TPS pixels
to diodes (which is approximately 11) and multiply by the number of nearest neighbors
(which is nine excluding the reduction of nearest neighbors at the edges) with the number
of diodes evaluated by each field, respectively. For example:
11(TPS pixels/diode) x 9 (nearest neighbors) x 188 (diodes) = 18,162 pixels evaluated.
For comparison purposes, the percentage of pixels that did not meet such requirement for
each beam will be listed in the results section versus the results for MapCheck.

Beam Variables
Each beam in treatment plan has several parameters that make it unique. For
example, each beam has a different angle which is predetermined and selected by the
treatment planner. The numbers of beams that exist in a prostate treatment generally
vary from planner to planner. Traditionally, 4-7 beams are used for treatment of the
prostate. The reasoning behind using 7 beams in this case is primarily based on the
dose conformity that this beam count offers. Duration of the beam time is also
different; this is primarily based on the dose being delivered from the beam. For
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example, if the beam has to travel through a larger depth the duration of the beam
will increase so that the dose required to the isocenter is administered. It should be
mentioned that each beam contains its own beam leaf sequence. The beam leaf
sequence is comprised of duration of beam time, and change in collimation as a
function of position and time, which is known as the sliding window technique. For a
fixed gantry position, the position formed by each pair of opposing MLC leaves is
swept across the target volume under computer control, with the radiation beam on,
to produce the desired fluence profiles. The setting of the leaf pair opening and its
speed for each MLC leaf pair is determined by the optimization algorithm in the
treatment planning system. The sliding window method for each beam may be best
represented with the schematic shown in figure III.11,

Figure III.11: Sliding window technique of delivering IMRT

where the dotted lines indicate positions of a leaf pair (x axis) as a function of beam time
(y axis). As the beam is turned both leaves move, with different speeds, from left to right.
The point P begins to receive radiation when the right leaf edge moves pass over it. It
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receives radiation until the left leaf blocks the beam. By controlling the movement of
leaves and therefore the “beam-on-time” duration between successive points, one can
deliver any desired intensity to point P, or any other point under this leaf pair. It should
be mentioned that although the angles when planned are different, all measurements are
taken at 180 degrees.

Analysis
For analysis purposes, we evaluated two treatment plans, referred to as Treatment Plan 1
(TP1) and Treatment Plan 2 (TP2), respectively. Each treatment plan was further divided
into beams 1-7 which are referred to as the Primary Tumor Volume I (PTV I-which is the
prescription to the tumor that includes the prostate and seminal vesicles), and beams 8-14
will be referred to as Primary Tumor Volume II (PTV II- which is the prescription to the
tumor that includes the prostate only). The accuracy of dose administered to the tumor
volume is based on the average percentage difference results, which is the quantitative
comparison of the dose distribution between the measured and calculated. The average
percentage difference between TPS and measurements was calculated and reported for
PTVI and PTVII of both TP1 and TP2 for both the MapCheck device and EDR2 film.
The EDR2 film was analyzed with the RIT software which employs the calculation given
in equationIII.2, evaluating 9 gammas per pixel based on the input criteria, and arriving at
a percentage difference using equation III.3. For the MapCheck device, the number of
diodes that passed/failed was calculated with the MapCheck software based on the input
criteria; specifically the calculation procedure given in figure III.7. Additionally, the
software computes a percentage difference given in equation III.3.
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Equation III.3

The evaluation of time efficiency was measured by the average time taken to
perform the following conditions of all 14 beams of TP1 and TP 2 using both the
MapCheck device and film: 1) Exposure Time and Setup, 2) Developing/Processing, 3)
Scanning, and 4) Analysis.
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IV. RESULTS
The results of the measurements done for this study have been summarized in the
following tables. In addition, results based on time efficiency will be presented following
the experimental data.
Table IV.1 and Table IV.2 presents the results of Treatment Plan (TP) 1 for the
EDR2 film and MapCheck device, respectively, with a specified criteria of 3mm DTA
and 3% dose tolerance for beam measurements 1-7 which are the beams that comprise the
dose delivered to Primary Tumor Volume (PTV) I which contain the prostate and seminal
vesicles and the intended composite dose was 4500 cGy. The software of MapCheck and
RIT apply equation (III.2) for the aforementioned criteria. It should be noted that
percentage differences refer to the percentage of measurement pixels for film and
measurement diodes for MapCheck that failed the specified criteria.
EDR2 Film
Beam #

Energy
Total # of pixels

Total # of agreed
pixels

Percentage
difference

1

6MV

18224

16009

12.15%

2

6MV

14268

13390

6.15%

3

6MV

18487

17279

6.53%

4

6MV

15748

13831

12.17%

5

6MV

17688

16340

7.62%

6

6MV

16492

15410

6.56%

7

6MV

16384

14678

10.41%

Table IV.1: Analysis for TP 1 (beams1-7) using EDR 2 film
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MapCheck
Beam #

Energy

Total #
of
diodes

1

6MV

188

Total #
of
agreed
diodes
185

2

6MV

169

169

0.00%

3

6MV

175

174

0.60%

4

6MV

182

181

0.60%

5

6MV

184

184

0.00%

6

6MV

160

160

0.00%

7

6MV

182

181

0.60%

Percentage
difference
1.60%

Table IV.2: Analysis for TP 1 (beams1-7) using MapCheck

The previous measurements of the MapCheck device yielded an average
percentage difference of 0.49% with a standard deviation of 0.58%. The EDR2 film
yielded an average percentage difference of 8.80% with a standard deviation of 2.70%.
Table IV.3 and Table IV.4 gives the percentage differences using the same
treatment plan-TP1- for the EDR2 film and MapCheck, respectively, which represents
the analysis of a region containing only the prostate (called PTV II) an intended total
delivery of 3500cGy. This set of beams is generally referred to as the “boost” of a
treatment. It should be noticed that the accuracy for EDR2 film had an overall increase in
the average percentage difference of pixels that failed the criteria. It can be noticed that
MapCheck results remained consistent throughout PTV I and PTV II.
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EDR2 Film
Beam #

Energy

8

6MV

17526

Total # of agreed
pixels
15270

9

6MV

16200

15030

10

6MV

15250

14270

6.42%

11

6MV

17955

15933

11.26%

12

6MV

17423

15992

8.21%

13

6MV

14625

13288

9.14%

14

6MV

15960

14981

6.13%

Total # of pixels

Percentage
difference
12.87%
7.22%

Table IV.3: Analysis for TP 1 (beams 8-14) using EDR 2 film

MapCheck
Beam #

Energy

Total #
of
diodes

1

6MV

187

Total #
of
agreed
diodes
185

2

6MV

166

165

0.70%

3

6MV

175

173

1.20%

4

6MV

181

181

0.00%

5

6MV

183

182

0.60%

6

6MV

157

157

0.00%

7

6MV

182

182

0.00%

Percentage
difference
1.11%

Table IV.4: Analysis for TP 1 (beams 8-14) using MapCheck

The previous measurements of the MapCheck device yielded an average
percentage difference of 0.53% (which is slight improvement of PTV I) with a standard
deviation of 0.52%. The EDR2 film yielded an average percentage difference of 8.75% (a
slight improvement of PTV I) with a standard deviation of 0.2.53%.
Table IV.3 gives the PTV I results for TP 2. It can be noted that the PTV I results
for TP 2 degraded with an overall average percentage difference increase in both the
MapCheck device and EDR 2 film measurements that failed the criteria. Another
important result was the aberrations for beams 1and 3 (which are in bold) in the EDR2
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film measurements. It should be mentioned that there was an average increase of pixels
and diodes measured in TP 2 than in TP 1.
EDR2 Film
Beam #

Energy

Total # of
pixels

1

6MV

17792

Total # of
agreed
pixels
13607

2

6MV

18753

16950

9.61%

3

6MV

19890

16178

18.66%

4

6MV

18886

16876

10.64%

5

6MV

17816

15726

11.73%

6

6MV

16750

14895

11.07%

7

6MV

19460

17955

7.73%

Percentage
difference
23.52%

Table IV.5: Analysis for TP 2(beams 1-7) using EDR2 film.

MapCheck
Beam #

Energy

Total # of
diodes

1

6MV

204

Total # of
agreed
diodes
197

2

6MV

200

198

1.00%

3

6MV

191

187

2.10%

4

6MV

201

197

2.00%

5

6MV

192

190

1.10%

6

6MV

178

178

0.00%

7

6MV

196

191

2.60%

Percentage
difference
3.51%

Table IV.6: Analysis for TP 2(beams 1-7) using MapCheck.

The previous measurements of the MapCheck device yielded an average
percentage difference of 1.76% with a standard deviation of 1.16%. The EDR2 film
yielded an average percentage difference of 13.28% with a standard deviation of 5.67%.
The cause of the aberration in beams 1 and 3 can be shown in the following figures:
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Figure IV.1: Horizontal profile of measured vs. calculated of beam1 for EDR2 film (superior solid
line-measured profile, dotted line- TPS profile, inferior solid line- dose difference profile between
measured and TPS)

49

Figure IV.2: Horizontal profile of measured vs. calculated of beam3 for EDR2 film (superior solid
line-measured profile, dotted line- TPS profile, inferior solid line- dose difference profile between
measured and TPS)

Figure IV.3: Vertical profile of measured vs. calculated of beam3 for EDR2 film (superior solid
line-measured profile, dotted line- TPS profile, inferior solid line- dose difference profile between
measured and TPS)

As one may see, there is a huge underdose in the Figure IV., and a solid overdose
in Figure IV.2. In addition, it should be mentioned that the abutment or penumbral region
(edges of the profile) of the measured profile has a sharp cutoff in comparison to the TPS
profile, which is prevalent in a majority of both horizontal and vertical profiles. A typical
profile is shown in Figure IV.3 where there is solid agreement between the measured and
calculated vertical profile.
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Table IV.4 gives the PTV II results for TP 2. The agreement and consistency of
the EDR2-film PTV II measurements showed much improvement versus the PTV I
results in a decreased average percentage of pixels and diodes that did not pass the
criteria.

EDR2 Film
Beam #

Energy

Total # of
pixels

8

6MV

17423

Total # of
agreed
pixels
16588

9

6MV

16520

15342

7.13%

10

6MV

17292

16192

6.36%

11

6MV

17820

16709

6.23%

12

6MV

18760

18032

3.88%

13

6MV

15625

14825

5.12%

14

6MV

17018

15855

6.83%

Percentage
difference
4.79%

Table IV.7: Analysis for TP 2 (beams 8-14) using EDR 2 film

MapCheck
Beam #

Energy

Total # of
diodes

8

6MV

189

Total # of
agreed
diodes
186

9

6MV

180

179

0.60%

10

6MV

184

184

0.00%

11

6MV

192

190

1.10%

12

6MV

187

187

0.00%

13

6MV

177

177

0.00%

14

6MV

185

185

0.00%

Percentage
difference
1.60%

Table IV.8: Analysis for TP 2 (beams 8-14) using MapCheck

The previous measurements of the MapCheck device yielded an average
percentage difference of 0.66% with a standard deviation of 0.47%. The EDR2 film
yielded an average percentage difference of 5.76% with a standard deviation of 1.19%.
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The following table represents the time taken to perform the various processes
involved in measuring and evaluating the given conditions. As one may see, much less
time is spent in the evaluation and data collection for the MapCheck device than EDR2
film. It is very indicative that the MapCheck system is more time efficient and thus a
more clinically prudent measurement device.

Conditions

EDR2-Film

MapCheck

Exposure Time and Setup
Developing/Processing
Scanning
Analysis

1.5hrs

50 mins

40 mins

n/a

15 mins

n/a

1.5hrs
Table IV.9: Time efficiency data
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20 mins
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V. DISCUSSION
The purpose of this study was to assess the ability of two dosimetric tools, EDR2
film and MapCheck, to accurately measure the dose distribution computed by the CMS
Treatment Planning System. In addition, the study compared which tool was more
feasible on the basis of time for clinical use. Based on the different methods of
calculation, I was unable to discern which clinical tool was a more accurate measurement
device for IMRT planar doses. However, MapCheck did prove to be a much more time
efficient than film.
It should be mentioned that the density of the buildup and measurement depth for
both the MapCheck device and EDR 2 measurements is different. The MapCheck device
uses an inherent buildup of 2.4cm of Plexiglas with a density of 1.33g/cm3, whereas the
EDR 2 film measurements used a solid water phantom slab buildup of 3.2cm with an
average density of 1.00g/cm3. This difference in measurement depth and density of the
buildup didn’t have an effect on the measurements for the MapCheck system as expected
because the MapCheck device was CT’d into the TPS-which calculates the dose based on
the CT values for the MapCheck device-using a measurement depth of 2.4cm and a
density of 1.33g/cm3. EDR 2 film measurements, however, were not as accurate. It
should be expected that some uncertainty be associated with having a different phantom
material CT’d into the TPS, but not substantially considering the equivalent depth of
material for was used for exposing the EDR2 film.
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An important factor in this study was the difference in calculation methods. The
Mapcheck software employs much less stringent conditions: 1) A diode will pass if it’s
within p% of the TPS pixel it superimposes 2) A diode will pass if within a 3mm radius it
finds a TPS pixel above and below the dose measured by the diode. Additionally, there
exist 11 TPS pixels for every diode, which makes it easier to meet the desired input
criteria. The film analysis software, however, employs a much more rigorous calculation
method. The software utilizes a nearest neighbor sampling, which scores a gamma for
each neighbor (approximately 9 gamma calculations per film pixel). This method yields
approximately 22,500 evaluated gammas for a 10x10 cm2 field, which makes it a much
more difficult for obtaining desired acceptance criteria. Therefore, an accuracy
comparison is unachievable unless the film software is manipulated to reduce the number
of calculations or by placing the same conditions as the MapCheck software.
A way to rectify the accuracy analysis problem may be accomplished in a very
straightforward manner. One would have to obtain raw image data from the proprietary
software from R.I.T, and import it into a general purpose image analysis package (i.e.
Matlab) and apply the same calculation algorithm: 1) nearest neighbor calculation
method used by R.I.T. or 2) p% dose tolerance/Distance to agreement calculation method
that MapCheck utilizes.

Both calculation algorithms would suffice, but the more

appropriate method would be the MapCheck algorithm because IMRT verification is a
crude measure of the actualized treatment, and an exhausting algorithm like the nearest
neighbor doesn’t yield more significant information.
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For the MapCheck device, the average percentage of measurement points that
didn’t match up with the TPS for PTV I and II of TP 1 and PTV II of TP 2 was low,
around 0.5%. However, there was worse agreement in the case of PTV I of TP2 with an
approximate disagreement increase of 1.2%. This could be attributed to a few factors, but
the most reasonable would be the position of the diodes in the irradiated field due to a
positioning error. Good positioning of the device is essential since the calibration factors
that are applied to each diode for absolute dose are based on the array calibration which
was performed with vast precision with respect to positioning. In IMRT, there exist many
high dose gradient regions which if diodes are positioned in the area where these high
gradient regions exist; it may cause an adverse reading error for the diode.
For the EDR2 film, the percentage of measurement points of Test Patient 1 that
did not agree with TPS for PTV I and PTV II was between 6.2% and 12.2%, and 6.1%
and 12.9%, respectively, with a standard deviation of 2.70% and 2.53%, respectively.
The percentage of measurement points of Test Patient 2 that didn’t agree with TPS for
PTV I and PTV II was between 7.7% and 23.5%, and 3.9% and 7.1%, respectively, with
a standard deviation of 5.67% and 1.19%, respectively. However, if one excludes the two
aberrations for the measurements of PTV I for TP 2 (beams 1&3), the percentage of
measurement points that didn’t agree would be between 7.73% and 11.7%.
Although EDR2 film has a high spatial resolution, and is the standard (along with
ionization chambers) for verification of IMRT plans, it contains many uncertainties that
create differences between the measured and the TPS calculated values. The most basic
uncertainty that arises is due to the time delay effect. The time delay effect refers to the
time between exposing and processing EDR2 film which can affect its OD response by as
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much as 6%12. This effect is well exhibited in TP2, where the percent of measurement
points that didn’t agree becomes lessened in the PTV II measurements. It is generally
recommended that one hour be given between exposure and processing in order to allow
the EDR2 film to reach 99% of its stable OD value. Unfortunately, the recommended
minimum of an hour needed was not given to the measurements of PTV I of TP 2, thus
resulting in a much worse percent of measurement points that did not pass.
Another effect that is very evident from observing the horizontal profiles (fig. IV
1&2) is the loss of low dose data in the abutment region, which is the region outside the
primary dosing region (for example, pixels 1 to around 10 in Fig. IV.1).Generally, if you
set up the scanner to accurately record the OD in regions where OD is high, you lose
accuracy and dynamic resolution of the low dose, thereby reducing the agreement
between the measured and calculated values.
An additional observation that was made was the under-response of dose in the
horizontal profiles which can possibly due to the intermittency effect. The intermittency
effect refers to change in a film’s OD response when exposed to many small doses
compared to a single exposure of the same total dose. It is said that this can cause
anywhere from a 2-5%12 OD under-response, which would yield a significant difference
in measured to calculated values. This is clinically relevant for IMRT verifications
because step and shoot techniques deliver short bursts of radiation over a substantial
period of time. It should be mentioned that positioning of the film is as or more important
than any other factors previously mentioned. The inaccuracy in positioning was
noticeable in fig IV 1, which coincidentally was one of the beams which did not pass the
mean gamma index.
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Albeit some of the reported inaccuracies reported if one inspects some of the
profiles that showed great agreement (as in Figure IV.3), one may see that if the similar
calculation method was used as for the MapCheck device, there would be much greater
agreement. Additionally, it is very obvious from Figures IV.1 and IV.2 that processing
affected the dose since the profiles match up very closely laterally and longitudinally
with the exception of the scaling issue (underdose or overdose).
The measurements for the MapCheck device showed much more promise than
that of the EDR2 film. However, it should be mentioned that there are considerable
limitations.
•

Resolution: For EDR2 film, the optical density points (measured points) are
almost one to one with the calculated points of the treatment planning system.
This type of resolution can not be achieved with the MapCheck device since the
diodes within the array are fixed at positions with distances of 7mm, and
generally a max of 210 diodes are used to evaluate the dose distribution compared
to 20,000 pixels of the film.

•

Limited depth choices: Generally, measurements are made using a solid water
phantom buildup of 5cm or greater for film. However, this type of buildup is not
recommended for diode array devices since the increase in buildup increases
scatter which can cause damage.
Other potential problems exist for the MapCheck system. If one diode within the

system is non functional, then it has to be sent back to the manufacturer, which can set
back the clinic in terms of being able to perform IMRT plans. This problem creates
financial burden on the clinic because the planning of such cases will not be able to be
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executed (if this happens to be your only source for verifying IMRT plans). An
outstanding issue of concern for clinic’s using the MapCheck device is neutron
contamination, which increases the rate of damage for diodes. Neutron contamination is
very prevalent in beams of energies greater than 10MV. Therefore, facilities using
MapCheck as their IMRT quality assurance (QA) device might be restricted if treatment
plans necessitate higher energies. In addition, it has been shown that N-type diodes have
a drop in sensitivity of 1.5 -2.2% per 1000gy of absorbed dose14. The average IMRT QA
delivers approximately 4Gy per treatment plan, which means that there could exist a 2%
(rounded estimate) drop in sensitivity for each diode every 250 patients. If this is the
case, then an array calibration should be performed semi annually so that correction
factors applied to absolute dose measurements are accurate.
A study potentially useful for future research would be to measure the impact of
using different buildup material for dose distribution measurements. This would clarify if
the buildup material had an impact on fluence map single beam measurements.
Additionally, and perhaps more importantly, a study that involved rewriting the
film analysis software to match the calculation method of the MapCheck device. This
would be an accurate representation of the comparison between the MapCheck device
and EDR2 film for the measurement of IMRT planar doses.
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VI. Conclusion
The time efficiency of the MapCheck device makes it a good quality assurance tool for
fluence map measurements of IMRT plans in a clinical setting. Mapcheck was shown to
have an overall lower percentage of diodes that failed with the given input tolerances.
Additionally, the time required to perform measurements and analysis was greatly
reduced with the MapCheck device. Albeit the high resolution and cost efficiency of
EDR2 Film, it proved to be a very unreliable tool for making single beam IMRT
measurements. The time required to make measurements is almost doubled, and the
entire process from set-up to analysis is tripled, which is very inconvenient for a busy
clinical setting. The accuracy of film is also lessened due to its sensitive nature, which
requires almost ideal processing conditions and calibration. However, the accuracy may
be improved by utilizing a less rigorous calculation method, which is the hope of future
studies. In conclusion, from this study, my contention is that the MapCheck device is a
prudent choice for a time efficient IMRT measurement tool.
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